N,N-dibenzyl-2-bromoethanamine → HCID 131710085, compound
Reaction equation
[CH2:1]([N:8]([CH2:28]C1C=CC=CC=1)[CH2:9][CH2:10][N:11]1[C:20]2[C:15](=[CH:16][CH:17]=[C:18]([CH3:21])[N:19]=2)[C:14](=[O:22])[C:13]([C:23]([O:25][CH2:26][CH3:27])=[O:24])=[CH:12]1)C1C=CC=CC=1.C(N(CC1C=CC=CC=1)CCBr)C1C=CC=CC=1>>[CH3:28][N:8]([CH3:1])[CH2:9][CH2:10][N:11]1[C:20]2[C:15](=[CH:16][CH:17]=[C:18]([CH3:21])[N:19]=2)[C:14](=[O:22])[C:13]([C:23]([O:25][CH2:26][CH3:27])=[O:24])=[CH:12]1Participants
3
Procedure
1-[2-(Dibenzylamino)ethyl]-1,4-dihydro-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acid, ethyl ester, m.p. 170°-174° (72 %) (2-Dibenzylaminoethyl bromide).
Sources & evidence
- ORD record
- ord-3812b6511f3c4cd98d053c7526919f59
- Source dataset
- uspto-grants-1976_03
- Patent number
- US03943141
Reaction notes
Loading…